Immusmol
Small-molecule antibodies and ELISA kits for academic researchers and biotechnology companies
Highlights
- New on EvolcAdded 2026-10-30
About Immusmol
Immusmol develops antibodies targeting small molecules and ELISA kits for their detection and measurement. Its products support imaging and quantification in biological samples, and it offers custom antibody development services.
Customers include academic researchers and biotechnology companies. Products are sold worldwide through direct e-commerce and a distributor network.
Founded in 2012 in Bordeaux, France, Immusmol also operates a laboratory and offices in Bordeaux. The company has around twenty employees according to company information.
Product: Small-molecule antibodies, ELISA kits, staining kits and custom antibody development services.
Jobs at Immusmol
Leadership
- Alban Bessède · Founder & CEOSource: company website
- Loic Cerf · Chief Operating OfficerSource: company website
More biotech & pharma companies
Innobiomil
Cell culture media, feeds and contract manufacturing for biopharma, vaccine and biosimilar developersNew on EvolcInnolea
Plant genetics and genomics research for rapeseed and sunflower breeding companies and research partnersNew on EvolcInnovative Diagnostics
Develops PCR and ELISA diagnostic kits for veterinary and zoonotic diseases, sold to public and private labs worldwideNew on EvolcInorevia
Benchtop walk-away automation for NGS library prep, sold to genomics core labs, clinical labs and biotech R&D teamsNew on EvolcInovarion
Contract biomedical research services for pharma and biotech teams, from discovery and preclinical work to regulatory affairsNew on EvolcInovotion
In vivo oncology efficacy and toxicity assays for drug developers and cancer researchersNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Complianz
- Elementor
- Google Ads
- Google Analytics 4
- Google Tag Manager
- Google reCAPTCHA
- WooCommerce
- WordPress
- jQuery
- nginx